Clinical meaning of sarcopenia in patients undergoing endoscopic treatment
With increasing global life expectancy, the significance of geriatric assessment parameters has increased. Sarcopenia is a crucial assessment parameter and is defined as the age-related loss of muscle mass and strength. Sarcopenia is widely acknowledged as a risk factor for postoperative complications in diverse advanced malignancies and has a detrimental effect on the long-term prognosis. While most studies have primarily concentrated on the correlation between sarcopenia and advanced cancer, more recent investigations have focused on the relationship between sarcopenia and early-stage cancer. Endoscopic submucosal dissection (ESD), which is less invasive than surgical intervention, is extensively employed in the management of early-stage cancer, although it is associated with complications such as bleeding and perforation. In recent years, several reports have revealed the adverse consequences of sarcopenia in patients with early-stage cancer undergoing ESD. This literature review briefly summarizes the recent studies on the association between sarcopenia and ESD.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
Clinical endoscopy - (2024) vom: 22. März |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hisada, Hiroyuki [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Aged |
|---|
| Anmerkungen: |
Date Revised 22.03.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.5946/ce.2023.193 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370045653 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370045653 | ||
| 003 | DE-627 | ||
| 005 | 20240323002043.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240323s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.5946/ce.2023.193 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1341.xml |
| 035 | |a (DE-627)NLM370045653 | ||
| 035 | |a (NLM)38514988 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hisada, Hiroyuki |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Clinical meaning of sarcopenia in patients undergoing endoscopic treatment |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 22.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a With increasing global life expectancy, the significance of geriatric assessment parameters has increased. Sarcopenia is a crucial assessment parameter and is defined as the age-related loss of muscle mass and strength. Sarcopenia is widely acknowledged as a risk factor for postoperative complications in diverse advanced malignancies and has a detrimental effect on the long-term prognosis. While most studies have primarily concentrated on the correlation between sarcopenia and advanced cancer, more recent investigations have focused on the relationship between sarcopenia and early-stage cancer. Endoscopic submucosal dissection (ESD), which is less invasive than surgical intervention, is extensively employed in the management of early-stage cancer, although it is associated with complications such as bleeding and perforation. In recent years, several reports have revealed the adverse consequences of sarcopenia in patients with early-stage cancer undergoing ESD. This literature review briefly summarizes the recent studies on the association between sarcopenia and ESD | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Aged | |
| 650 | 4 | |a Endoscopic submucosal dissection | |
| 650 | 4 | |a Neoplasms | |
| 650 | 4 | |a Prognosis | |
| 650 | 4 | |a Sarcopenia | |
| 700 | 1 | |a Tsuji, Yosuke |e verfasserin |4 aut | |
| 700 | 1 | |a Kuribara, Hikaru |e verfasserin |4 aut | |
| 700 | 1 | |a Miyata, Ryohei |e verfasserin |4 aut | |
| 700 | 1 | |a Oshio, Kaori |e verfasserin |4 aut | |
| 700 | 1 | |a Mizutani, Satoru |e verfasserin |4 aut | |
| 700 | 1 | |a Nakagawa, Hideki |e verfasserin |4 aut | |
| 700 | 1 | |a Cho, Rina |e verfasserin |4 aut | |
| 700 | 1 | |a Sakuma, Nobuyuki |e verfasserin |4 aut | |
| 700 | 1 | |a Miura, Yuko |e verfasserin |4 aut | |
| 700 | 1 | |a Mizutani, Hiroya |e verfasserin |4 aut | |
| 700 | 1 | |a Ohki, Daisuke |e verfasserin |4 aut | |
| 700 | 1 | |a Yakabi, Seiichi |e verfasserin |4 aut | |
| 700 | 1 | |a Takahashi, Yu |e verfasserin |4 aut | |
| 700 | 1 | |a Sakaguchi, Yoshiki |e verfasserin |4 aut | |
| 700 | 1 | |a Kakushima, Naomi |e verfasserin |4 aut | |
| 700 | 1 | |a Yamamichi, Nobutake |e verfasserin |4 aut | |
| 700 | 1 | |a Fujishiro, Mitsuhiro |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical endoscopy |d 2011 |g (2024) vom: 22. März |w (DE-627)NLM218997000 |x 2234-2400 |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:22 |g month:03 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.5946/ce.2023.193 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 22 |c 03 | ||